CAMBRIDGE, Mass. & SAN DIEGO, Apr 06, 2014 (BUSINESS WIRE) -- Agios Pharmaceuticals, Inc. AGIO +21.98% , a leader in the fields of cancer metabolism and inborn errors of metabolism, announced that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results